SuperworthHemab Therapeutics shares outstanding COAG
Diluted shares outstanding, averaged over each quarter, from 2025.
- Latest quarter, to Jun 30, 2026
- 30.1M
- On a year earlier
- +3083.0%
- more shares
Hemab Therapeutics had 30.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 3083.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 30.1M | +3083% | |
| Q1 FY26 | 946K | +0% | |
| Q2 FY25 | 946K | n/a | |
| Q1 FY25 | 946K | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Hemab Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.